These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30284497)

  • 1. CCL25 chemokine-guided stem cell attraction: an assessment of possible benefits and risks.
    Spinnen J; Ringe J; Sittinger M
    Regen Med; 2018 Oct; 13(7):833-844. PubMed ID: 30284497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion.
    Johnson EL; Singh R; Singh S; Johnson-Holiday CM; Grizzle WE; Partridge EE; Lillard JW
    World J Surg Oncol; 2010 Jul; 8():62. PubMed ID: 20649989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCL25/CCR9 Signal Promotes Migration and Invasion in Hepatocellular and Breast Cancer Cell Lines.
    Zhang Z; Sun T; Chen Y; Gong S; Sun X; Zou F; Peng R
    DNA Cell Biol; 2016 Jul; 35(7):348-57. PubMed ID: 27008282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells and their chondrogenic differentiated and dedifferentiated progeny express chemokine receptor CCR9 and chemotactically migrate toward CCL25 or serum.
    Ullah M; Eucker J; Sittinger M; Ringe J
    Stem Cell Res Ther; 2013 Aug; 4(4):99. PubMed ID: 23958031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR9 and CCL25: A review of their roles in tumor promotion.
    Xu B; Deng C; Wu X; Ji T; Zhao L; Han Y; Yang W; Qi Y; Wang Z; Yang Z; Yang Y
    J Cell Physiol; 2020 Dec; 235(12):9121-9132. PubMed ID: 32401349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR9-CCL25 interactions promote cisplatin resistance in breast cancer cell through Akt activation in a PI3K-dependent and FAK-independent fashion.
    Johnson-Holiday C; Singh R; Johnson EL; Grizzle WE; Lillard JW; Singh S
    World J Surg Oncol; 2011 May; 9():46. PubMed ID: 21539750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the CCL25-CCR9 axis in beta-cell function: potential for therapeutic intervention in type 2 diabetes.
    Atanes P; Lee V; Huang GC; Persaud SJ
    Metabolism; 2020 Dec; 113():154394. PubMed ID: 33058852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine 25-induced signaling suppresses colon cancer invasion and metastasis.
    Chen HJ; Edwards R; Tucci S; Bu P; Milsom J; Lee S; Edelmann W; Gümüs ZH; Shen X; Lipkin S
    J Clin Invest; 2012 Sep; 122(9):3184-96. PubMed ID: 22863617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer.
    Singh R; Stockard CR; Grizzle WE; Lillard JW; Singh S
    Int J Oncol; 2011 Aug; 39(2):373-81. PubMed ID: 21637913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCL25/CCR9 interaction promotes the malignant behavior of salivary adenoid cystic carcinoma
    Chai S; Wen Z; Zhang R; Bai Y; Liu J; Li J; Kongling W; Chen W; Wang F; Gao L
    PeerJ; 2022; 10():e13844. PubMed ID: 36003306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR9 mediates PI3K/AKT-dependent antiapoptotic signals in prostate cancer cells and inhibition of CCR9-CCL25 interaction enhances the cytotoxic effects of etoposide.
    Sharma PK; Singh R; Novakovic KR; Eaton JW; Grizzle WE; Singh S
    Int J Cancer; 2010 Nov; 127(9):2020-30. PubMed ID: 20127861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCR9-CCL25 interaction suppresses apoptosis of lung cancer cells by activating the PI3K/Akt pathway.
    Li B; Wang Z; Zhong Y; Lan J; Li X; Lin H
    Med Oncol; 2015 Mar; 32(3):66. PubMed ID: 25691296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCL25 mediates migration, invasion and matrix metalloproteinase expression by breast cancer cells in a CCR9-dependent fashion.
    Johnson-Holiday C; Singh R; Johnson E; Singh S; Stockard CR; Grizzle WE; Lillard JW
    Int J Oncol; 2011 May; 38(5):1279-85. PubMed ID: 21344163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCR9 in cancer: oncogenic role and therapeutic targeting.
    Tu Z; Xiao R; Xiong J; Tembo KM; Deng X; Xiong M; Liu P; Wang M; Zhang Q
    J Hematol Oncol; 2016 Feb; 9():10. PubMed ID: 26879872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokine (C-C motif) ligand 25 expressed by trophoblast cells and leukocytes bearing its receptor Ccr9: An alliance during embryo implantation?
    Weingrill RB; Hoshida MS; Martinhago CD; Correa-Silva S; Cardoso E; Palmeira P; Marinho CRF; Bevilacqua E
    Am J Reprod Immunol; 2018 Jan; 79(1):. PubMed ID: 29154408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCL25/CCR9 interactions are not essential for colitis development but are required for innate immune cell protection from chronic experimental murine colitis.
    Wurbel MA; Le Bras S; Ibourk M; Pardo M; McIntire MG; Coco D; Geha RS; Fiebiger E; Snapper SB
    Inflamm Bowel Dis; 2014 Jul; 20(7):1165-76. PubMed ID: 24874458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCR9-mediated signaling through β-catenin and identification of a novel CCR9 antagonist.
    Lee S; Heinrich EL; Li L; Lu J; Choi AH; Levy RA; Wagner JE; Yip ML; Vaidehi N; Kim J
    Mol Oncol; 2015 Oct; 9(8):1599-611. PubMed ID: 26003048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of beta7 integrin and the chemokine/chemokine receptor pair CCL25/CCR9 in modeled TNF-dependent Crohn's disease.
    Apostolaki M; Manoloukos M; Roulis M; Wurbel MA; Müller W; Papadakis KA; Kontoyiannis DL; Malissen B; Kollias G
    Gastroenterology; 2008 Jun; 134(7):2025-35. PubMed ID: 18439426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCL25/CCR9 interactions regulate the function of iNKT cells in oxazolone-induced colitis in mice.
    Zhu S; Bing Y; Wang X; Yu Q; Wang Y; Xu S; Song L; Wang X; Xia B; Zhu Y; Zhou R
    PLoS One; 2014; 9(6):e100167. PubMed ID: 24936795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCR9 Promotes Migration and Invasion of Lung Adenocarcinoma Cancer Stem Cells.
    Lu L; Du H; Huang H; Wang C; Wang P; Zha Z; Wu Y; Liu X; Weng C; Fang X; Li B; Mao H; Wang L; Guan M; Liu G
    Int J Med Sci; 2020; 17(7):912-920. PubMed ID: 32308544
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.